23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Targeted radionuclide therapy (TRT) is a promising technique for cancer therapy. However, in order to deliver the required dose to the tumor, minimize potential toxicity in normal organs, as well as monitor therapeutic effects, it is important to assess the individualized internal dosimetry based on patient-specific data. Advanced imaging techniques, especially radionuclide imaging, can be used to determine the spatial distribution of administered tracers for calculating the organ-absorbed dose. While planar scintigraphy is still the mainstream imaging method, SPECT, PET and bremsstrahlung imaging have promising properties to improve accuracy in quantification. This article reviews the basic principles of TRT and discusses the latest development in radionuclide imaging techniques for different theranostic agents, with emphasis on their potential to improve personalized TRT dosimetry.

          Related collections

          Most cited references116

          • Record: found
          • Abstract: found
          • Article: not found

          MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.

          The accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet no. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on (177)Lu (lutetium) and its application in radiopharmaceutical therapy.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Image segmentation evaluation: A survey of unsupervised methods

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Immuno-PET: a navigator in monoclonal antibody development and applications.

              Monoclonal antibodies (mAbs) have been approved for use as diagnostics and therapeutics in a broad range of medical indications, but especially in oncology. In addition, hundreds of new mAbs, engineered mAb fragments, and nontraditional antibody-like scaffolds directed against either validated or novel tumor targets are under development. Immuno-positron emission tomography (PET), the tracking and quantification of mAbs with PET in vivo, is an exciting novel option to improve diagnostic imaging and to guide mAb-based therapy. In this review, recent technical advances leading to a jump ahead in mAb imaging are discussed. The availability of proper positron emitters, sophisticated radiochemistry, and advanced PET and PET-computed tomography scanners is crucial in these developments. Immuno-PET might play an important future role in cancer staging, in the improvement and tailoring of therapy with existing mAbs, and in the efficient development of novel mAbs. An overview of the preclinical and first clinical immuno-PET studies is provided.
                Bookmark

                Author and article information

                Journal
                Theranostics
                Theranostics
                thno
                Theranostics
                Ivyspring International Publisher (Sydney )
                1838-7640
                2017
                13 October 2017
                : 7
                : 18
                : 4551-4565
                Affiliations
                [1 ]Biomedical Imaging Laboratory, Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Macau SAR, China;
                [2 ]Dept of Radiology and Nuclear medicine, Ghent University, De Pintelaan 185 9000 Gent, Belgium;
                [3 ]AZ Maria Middelares, Buiten-Ring-Sint-Denijs 30, 9000 Gent, Belgium;
                [4 ]Dept of Nuclear Medicine, UZ Ghent-Ghent University, St-Pietersnieuwstraat 41, 9000 Gent, Belgium;
                [5 ]MEDISIP-ELIS-IBITECH-IMEC, Ghent University, St-Pietersnieuwstraat 41, 9000 Gent, Belgium;
                [6 ]Faculty of Health Sciences, University of Macau, Macau SAR, China.
                Author notes
                ✉ Corresponding authors: Stefaan Vandenberghe: Electronic mail: Stefaan.Vandenberghe@ 123456UGent.be ; Telephone: (32) 093325854. Greta S. P. Mok: Electronic mail: gretamok@ 123456umac.mo ; Telephone: (853) 8822-4491.

                Competing Interests: The authors have declared that no competing interest exists.

                Article
                thnov07p4551
                10.7150/thno.19782
                5695148
                29158844
                663c32e1-9439-4b2f-892e-3b91daa73e9f
                © Ivyspring International Publisher

                This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license ( https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.

                History
                : 23 February 2017
                : 25 July 2017
                Categories
                Review

                Molecular medicine
                nuclear medicine imaging,targeted radionuclide therapy,internal dosimetry,theranostic agents.

                Comments

                Comment on this article